A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety

A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety

The severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all sectors worldwide. Despite new vaccine technologies and mass administration of booster doses, the virus persists, and unknow...

Full description

Bibliographic Details
Main Author:	Md. Aminul Islam
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Infectious Medicine
Subjects:	SARS-CoV-2 Variants & subvariants Vaccines Booster doses Immunity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772431X23000448

Similar Items

Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study
by: Denggao Peng, et al.
Published: (2024-01-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
by: Jéssica Pires Farias, et al.
Published: (2023-12-01)

Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?
by: Srijan Chatterjee, et al.
Published: (2023-06-01)

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
by: Ranjan K. Mohapatra, et al.
Published: (2022-11-01)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
by: Yuntao Zou, et al.
Published: (2022-07-01)

The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
by: Ka-Wa Khong, et al.
Published: (2022-11-01)

Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
by: Jun Wu, et al.
Published: (2023-06-01)

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
by: Joy-Yan Lam, et al.
Published: (2022-12-01)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022-03-01)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
by: Bibi Uhre Nielsen, et al.
Published: (2022-07-01)

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
by: Nando Reza Pratama, et al.
Published: (2022-12-01)

Saliva and Plasma Neutralizing Activity Induced by the Administration of a Third bnt162b2 Vaccine Dose
by: Micaela Garziano, et al.
Published: (2022-11-01)

Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain
by: Daniel Kwakye Nomah, et al.
Published: (2023-12-01)

Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
by: Nawal Al Kaabi, et al.
Published: (2023-01-01)

Effectiveness of Mix-and-Match Vaccination in Preventing SARS-CoV-2 Omicron Variant Infection in Taiwan: A Test-Negative Control Study
by: Yu-Tung Huang, et al.
Published: (2023-08-01)

Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
by: Haoyue Cheng, et al.
Published: (2022-07-01)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
by: Xiaofeng He, et al.
Published: (2023-10-01)

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people
by: Iván Sanz-Muñoz, et al.
Published: (2023-02-01)

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
by: Sindhu Ramesh, et al.
Published: (2021-10-01)

COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation
by: Camilla Mattiuzzi, et al.
Published: (2022-04-01)

Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyResearch in context
by: Ralf Duerr, et al.
Published: (2023-11-01)

Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study
by: Marc Chadeau-Hyam, et al.
Published: (2022-06-01)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
by: Feyza Gül Özbay Kurt, et al.
Published: (2022-10-01)

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
by: Ahlam Chaqroun, et al.
Published: (2021-06-01)

The pros and cons of the second booster dose of the COVID-19 vaccine
by: Ehsan Mostafavi
Published: (2022-08-01)

COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
by: Wei-Chun Chen, et al.
Published: (2023-08-01)

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
by: Mascellino MT, et al.
Published: (2021-08-01)

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
by: Jing Lian Suah, et al.
Published: (2022-12-01)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021-10-01)

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
by: Marion Migueres, et al.
Published: (2022-02-01)

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
by: Ahmed I. Abulsoud, et al.
Published: (2023-01-01)

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
by: Gary McLean, et al.
Published: (2022-04-01)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
by: Alessandra Vergori, et al.
Published: (2022-08-01)

Inactivated COVID-19 vaccination and SARS-CoV-2 infection among Chinese adults in the “living with COVID” era
by: Hongbiao Chen, et al.
Published: (2024-02-01)

Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
by: Shashidhar Jaggaiahgari, et al.
Published: (2022-12-01)

Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine
by: Chalerm Liwsrisakun, et al.
Published: (2022-05-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

Real-World Effectiveness of a Booster Dose of the COVID-19 Vaccines among Japanese University Students
by: Shunsuke Miyauchi, et al.
Published: (2022-08-01)